Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent eylea australia?Sunitinib price philippines?Febuxostat patent expiry gout?Onglyza patent expiration date?Brand name for imipramine?
See the DrugPatentWatch profile for Alfuzosin
Alfuzosin is an alpha-1 blocker used for urinary symptoms related to benign prostatic hyperplasia (BPH). The best-known “brand” name is Uroxatral in the U.S.
Brand naming can vary by country and by the drug’s release type (for example, immediate-release versus extended-release tablets). In the U.S., Uroxatral is specifically marketed as an extended-release alfuzosin product.
Yes. Depending on the market, alfuzosin can be sold under different brand names and also as generics after brand exclusivity ends. For brand-level product and patent/exclusivity tracking, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/ [1]
Look at the label for the active ingredient (alfuzosin) and the brand name shown by your pharmacy. If you share the full label wording (brand name and whether it says extended-release/ER), it’s easier to confirm the exact product.
DrugPatentWatch.com tracks drug patents and related timelines; you can search for “alfuzosin” there to see which brand(s) and related exclusivity/patent information apply: https://www.drugpatentwatch.com/ [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Alfuzosin :